---
title: "C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286088253.md"
description: "On May 12, 2026, in Watertown, Massachusetts, C4 Therapeutics, Inc. (C4T) disclosed its financial performance for the first quarter ending on March 31, 2026. The company, listed on Nasdaq as CCCC, is focused on TPD science in the clinical stage of biopharmaceuticals. They also shared recent business accomplishments."
datetime: "2026-05-12T11:01:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286088253.md)
  - [en](https://longbridge.com/en/news/286088253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286088253.md)
---

# C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights

On May 12, 2026, in Watertown, Massachusetts, C4 Therapeutics, Inc. (C4T) disclosed its financial performance for the first quarter ending on March 31, 2026. The company, listed on Nasdaq as CCCC, is focused on TPD science in the clinical stage of biopharmaceuticals. They also shared recent business accomplishments.

### Related Stocks

- [CCCC.US](https://longbridge.com/en/quote/CCCC.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says](https://longbridge.com/en/news/286290495.md)